Skip to main content

Table 3 Incremental costs, QALYs DW gained and ICERs per individual 12-year-old over their whole lives (expected value analysis)

From: Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program

 

Baseline

Each intervention compared to no HPV vaccination

Incremental comparisons

Intervention 1G:Replicating the girls-onlyNZ program in 2011

Intervention 2G:Intensive girls-onlyprogram, school-based

Intervention 1G + B:Adding boysto the girlsNZ program in 2011

Intervention 2G + B:Adding boysto the intensive girlsprogram, school-based

[A] Intervention 2G c.f. Intervention 1G

[B] Intervention 1G + B c.f. Intervention1G

[D] Intervention 2G + B c.f. Intervention 2G

Net cost (NZ$)

Total population

$43,807

$81

$129

$235

$372

$47

$154

$244

QALYs DW gained (all individuals regardless of vaccination status)

Total population

26.2830

0.0045

0.0059

0.0059

0.0069

0.0014

0.0014

0.0010

Males

26.3533

0.0025

0.0032

0.0033

0.0038

0.0007

0.0009

0.0006

Females

26.2092

0.0066

0.0087

0.0085

0.0102

0.0021

0.0019

0.0015

ICER*

Total population

 

$18,100

$21,900

m

$53,700

$34,000

$111,000

$234,000

  1. *All ICERs rounded to nearest $100 or nearest $1,000 if > $100,000.